PTA is our method of choice if you want reproducible, efficient, and evenly amplified genomes from single cells for single nucleotide variant detection.”

Christopher Walsh
Bullard Professor of Neurology, Harvard Medical School Chief Division of Genetics, Boston Children’s Hospital Investigator, Howard Hughes Medical Institute


I have tried several whole-genome amplification methods, and none compare to the high reliability and high fidelity of PTA.”

Michael Lodato, Ph.D.
Assistant Professor
Department of Molecular, Cell, and Cancer Biology
University of Massachusetts Medical School


I am setting up my own lab and BioSkryb has been extremely supportive. We can use PTA to detect mutation with high-confidence, sensitivity, and accuracy in single cells. This really opens up a lot of interesting avenues for us, and places us in the right position to discover some very exciting new biology.”

Juan Garaycoechea
Group leader, Hubrecht Institute



The BioSkryb team was a great partner in assisting us with single-cell sequencing and analysis. They were responsive to our unique needs and the results and insights their technology provided far exceeded our expectations.

BioSkryb’s commitment to supporting us in our fight against cancer using cell and gene therapies was present every step of the way. We highly recommend them for their products, services, and a customer-centric approach.”

Susan Nichols
CEO, Falcon Therapeutics